Brazilian oncology chain announced a joint venture with a subsidiary of the Saudi Al Faisaliah Group to implement an oncology facility in Riyadh. Potential revenue at year five of the joint venture is estimated at USD 550 million.
LATEST NEWS
- Return of refugees boosts Syrian economy
- Book explores Lebanon’s history and diaspora
- How companies can attract Arab investment
- Morocco welcomes 14% more Brazilian tourists
- Brazilian education company now in Qatar
- Saudi Arabia’s non-oil GDP grows 0.6%
- Brazil-Arab Gallery #67
- BIG Studios partners with Arab producer
